Excision Medical Moves Heart Technology Company to Hankin Group’s Eagleview in Exton, PA
The medical device startup joins growing number of life sciences companies moving to the thriving mixed-use development
EXTON, PA (November 18, 2024) – Hankin Group, a vertically integrated real estate company, has announced that Excision Medical, a privately held medical device company focused on structural heart technology innovations, relocated its corporate headquarters to 260 Sierra Drive at Eagleview in Exton, PA.
The 12,276 square foot space is an expansion for the Malvern-based startup, which is focused on addressing the rapidly growing need for lifetime management of aortic stenosis through transformative leaflet modification technology. The move follows the company’s successful $11 million series A fundraise and marks the next phase of growth as Excision Medical prepares to transition from research & development to clinical testing.
“We are thrilled to officially move into our new space at Eagleview,” said Jason Keiser, Vice President of Operations, Excision Medical. “Throughout my professional career, I’ve always had an excellent experience with Hankin’s property management, and the customizable, Class A CDMO facility is exactly what we were looking for as we continue to develop the next evolution of structural heart products.”
“Excision Medical is the third business Jason and his partners have brought to Eagleview, a testament to the value master-planned, amenity-rich, and transit-oriented real estate delivers for companies across industries,” said Bob Hankin, CEO, Hankin Group. “We look forward to seeing their continued success at Eagleview for years to come.”
260 Sierra Drive is a fully-leased, 80,000 square foot facility designed for office, research & development, light manufacturing and assembly, warehouse, and pharmaceutical uses.
With more than one million square feet of life sciences, research, and development space, Eagleview is quickly becoming the premier destination for the life sciences sector in the greater Philadelphia region.
Most recently, Hankin Group welcomed KOKO Medical, a medical device and women’s health company, to 770 Pennsylvania Drive and Frontage Laboratories, a full spectrum CDMO, and Fruh Packaging, a Swiss pharmaceutical packaging company, to 240 Sierra Drive. Additional tenants include West Pharmaceutical Services, Takeda Pharmaceuticals, Castle Biosciences, DSM, Immunome, and more.
Eagleview is an award-winning, 800-acre mixed-use community located in Chester County, PA. The master planned development boasts over 1,000 residences, 2.5 million square feet of distinctive commercial office space, and over 50,000 square feet of prime retail space. Eagleview’s thoughtfully designed system of sidewalks, jogging paths, and greenways create a unique experience that seamlessly integrates the residential, commercial, and retail aspects of the community.
Excision Medical was represented by Mitch Reading of Tactix Advisors. Hankin Group was represented internally by Sam Sherrill.
For additional information on Eagleview, visit www.hankingroup.com/eagleview.
About Hankin Group
Located in Exton, Pennsylvania, Hankin Group is a full-service, family-owned real estate company who designs, develops, and manages residential and commercial properties. For more information about Hankin Group and its projects, please visit www.hankingroup.com.